Health and Fitness Health and Fitness
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces Presentation of .. h Annual Public Health Emergency Medical Counterm
[ Mon, Jan 10th 2011 ] - Market Wire
Thermo Fisher Scientific Announces HSR Clearance to Acquire Dionex
[ Mon, Jan 10th 2011 ] - Market Wire
Ligand???Chiva Pharmaceuticals????????????
[ Mon, Jan 10th 2011 ] - Market Wire
ACADIA Pharmaceuticals Announces $15 Million Private Placement
[ Mon, Jan 10th 2011 ] - Market Wire
NPS Pharmaceuticals Announces Completion of Treat .. istration Study of GATTEX in Short Bowel Syndrome
[ Mon, Jan 10th 2011 ] - Market Wire
Unigene Provides 2011 Business Outlook
[ Mon, Jan 10th 2011 ] - Market Wire
OPKO Health to Collaborate with Bristol-Myers Squibb on Blood Test for Alzheimera?s Disease
[ Mon, Jan 10th 2011 ] - Market Wire
BioSante Pharmaceuticals Confirms Female Sexual Dysfunction as an Unmet Medical Need
[ Mon, Jan 10th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Announces Opening o .. nrollment in U.S. Phase I Colorectal Cancer Study
[ Mon, Jan 10th 2011 ] - Market Wire
Medisafe 1 Technologies Receives Endorsement for .. tion From Israel's Pharmaceuticals Administration
[ Mon, Jan 10th 2011 ] - Market Wire
Pro-Pharmaceuticals Receives Positive FDA Feedbac .. cal Trial Design to Treat Patients With Colorecta
[ Mon, Jan 10th 2011 ] - Market Wire
Enzon to Begin Phase 1 Study of Novel Androgen Re .. ntagonist in Castration-Resistant Prostate Cancer
[ Mon, Jan 10th 2011 ] - Market Wire
U.S. PENNSAID SALES CONTINUE TO GROW
[ Mon, Jan 10th 2011 ] - Market Wire
Emergent BioSolutions Provides Preliminary 2010 Financial Results and Guidance for 2011
[ Mon, Jan 10th 2011 ] - Market Wire
American Medical Systems Announces Fourth Quarter 2010 Revenue Performance
[ Mon, Jan 10th 2011 ] - Market Wire
Human Genome Sciences Reports Progress Toward Sus .. nces 2011 Goals at JPMorgan Healthcare Conference
[ Mon, Jan 10th 2011 ] - Market Wire
Illumina Introduces the Next Generation of iSelect® Custom Genotyping
[ Mon, Jan 10th 2011 ] - Market Wire
Exelixisa? XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Sun, January 9, 2011
[ Sun, Jan 09th 2011 ] - Market Wire
AMAG Pharmaceuticals Provides Business Update
[ Sun, Jan 09th 2011 ] - Market Wire
Inhibitex Reports Positive Interim Safety and Ant .. hase 1b Study of HCV Nucleotide Inhibitor INX-189
[ Sun, Jan 09th 2011 ] - Market Wire
LecTec Corporation Announces Trial Adjourned Until April 11, 2011
[ Sun, Jan 09th 2011 ] - Market Wire
Vertex Announces Key Business Objectives To Suppo .. ir in Hepatitis C and Continued Progress in Other
Fri, January 7, 2011
[ Fri, Jan 07th 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP, Representing Invest .. oration, Announces Class Action Lawsuit and Seeks
[ Fri, Jan 07th 2011 ] - Market Wire
Synergy Pharmaceuticals kondigt nieuw klinisch ontwikkelingsplan voor Plecanatide aan
[ Fri, Jan 07th 2011 ] - Market Wire
Alkermes Provides Update on Advancing Product Portfolio and Outlines Business Goals for 2011
[ Fri, Jan 07th 2011 ] - Market Wire
Synergy Pharmaceuticals Announces New Clinical Development Plan for Plecanatide
[ Fri, Jan 07th 2011 ] - Market Wire
Biomagnetics Diagnostics Schedules Investor Update Conference Call
[ Fri, Jan 07th 2011 ] - Market Wire
Covidien anuncia disponibilidad de la tecnologa N .. sistema Drger Infinity® Acute Care System en Eur
[ Fri, Jan 07th 2011 ] - Market Wire
Synergy Pharmaceuticals anuncia nuevo plan de desarrollo clnico para plecanatide
[ Fri, Jan 07th 2011 ] - Market Wire
Medtronic CEO William Hawkins to Speak at J.P. Morgan Healthcare Conference

Medtronic CEO William Hawkins to Speak at J.P. Morgan Healthcare Conference


Published on 2011-01-07 14:47:14 - Market Wire
  Print publication without navigation


MINNEAPOLIS--([ BUSINESS WIRE ])--Medtronic, Inc. (NYSE: MDT), the worlda™s leading medical technology company, today announced it will participate in the 29th annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011, in San Francisco.

William Hawkins, chairman and chief executive officer of Medtronic, will speak to attendees of the conference at 10:00 a.m. PST (12:00 p.m. CST). Hawkins will provide remarks highlighting Medtronica™s plan to deliver sustainable top and bottom line growth. A live audio webcast of the presentation can be accessed by clicking on the Investors link on the Medtronic home page at [ http://www.medtronic.com ] on January 10, 2011.

About Medtronic
Medtronic, Inc. ([ www.medtronic.com ]), headquartered in Minneapolis, is the global leader in medical technology a" alleviating pain, restoring health, and extending life for millions of people around the world.

Contributing Sources